189 related articles for article (PubMed ID: 11207233)
1. Neonatal paroxetine withdrawal syndrome.
Stiskal JA; Kulin N; Koren G; Ho T; Ito S
Arch Dis Child Fetal Neonatal Ed; 2001 Mar; 84(2):F134-5. PubMed ID: 11207233
[TBL] [Abstract][Full Text] [Related]
2. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?
Isbister GK; Dawson A; Whyte IM; Prior FH; Clancy C; Smith AJ
Arch Dis Child Fetal Neonatal Ed; 2001 Sep; 85(2):F147-8. PubMed ID: 11561552
[No Abstract] [Full Text] [Related]
3. Paroxetine and neonatal withdrawal syndrome.
Pogliani L; Schneider L; Dilillo D; Penagini F; Zuccotti GV
BMJ Case Rep; 2010 Apr; 2010():. PubMed ID: 22736561
[TBL] [Abstract][Full Text] [Related]
4. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
Haddad PM; Pal BR; Clarke P; Wieck A; Sridhiran S
J Psychopharmacol; 2005 Sep; 19(5):554-7. PubMed ID: 16166193
[TBL] [Abstract][Full Text] [Related]
5. Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine.
Murray KL; Miller KM; Pearson DL
J Perinatol; 2007 Aug; 27(8):517-8. PubMed ID: 17653218
[TBL] [Abstract][Full Text] [Related]
6. Perinatal outcome following third trimester exposure to paroxetine.
Costei AM; Kozer E; Ho T; Ito S; Koren G
Arch Pediatr Adolesc Med; 2002 Nov; 156(11):1129-32. PubMed ID: 12413342
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels.
Knoppert DC; Nimkar R; Principi T; Yuen D
Ther Drug Monit; 2006 Feb; 28(1):5-7. PubMed ID: 16418684
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.
Sanz EJ; De-las-Cuevas C; Kiuru A; Bate A; Edwards R
Lancet; 2005 Feb 5-11; 365(9458):482-7. PubMed ID: 15705457
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine withdrawal in a neonate with historical and laboratory confirmation.
Jaiswal S; Coombs RC; Isbister GK
Eur J Pediatr; 2003 Oct; 162(10):723-4. PubMed ID: 12905013
[No Abstract] [Full Text] [Related]
10. Withdrawal reactions of a premature neonate after maternal use of paroxetine.
Nijhuis IJ; Kok-Van Rooij GW; Bosschaart AN
Arch Dis Child Fetal Neonatal Ed; 2001 Jan; 84(1):F77. PubMed ID: 11199858
[No Abstract] [Full Text] [Related]
11. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
Levinson-Castiel R; Merlob P; Linder N; Sirota L; Klinger G
Arch Pediatr Adolesc Med; 2006 Feb; 160(2):173-6. PubMed ID: 16461873
[TBL] [Abstract][Full Text] [Related]
12. Transient neonatal jitteriness due to maternal use of sertraline (Zoloft).
Santos RP; Pergolizzi JJ
J Perinatol; 2004 Jun; 24(6):392-4. PubMed ID: 15167880
[TBL] [Abstract][Full Text] [Related]
13. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
Fagan M
Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
[TBL] [Abstract][Full Text] [Related]
14. Neonatal signs following exposure to SSRIs.
Hashimoto K
Hum Psychopharmacol; 2005 Oct; 20(7):522. PubMed ID: 16184524
[No Abstract] [Full Text] [Related]
15. [Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].
Cissoko H; Swortfiguer D; Giraudeau B; Jonville-Béra AP; Autret-Leca E
Arch Pediatr; 2005 Jul; 12(7):1081-4. PubMed ID: 15964522
[TBL] [Abstract][Full Text] [Related]
16. SSRIs and the developing brain.
Ruchkin V; Martin A
Lancet; 2005 Feb 5-11; 365(9458):451-3. PubMed ID: 15705440
[No Abstract] [Full Text] [Related]
17. Serotonin syndrome associated with nefazodone and paroxetine.
John L; Perreault MM; Tao T; Blew PG
Ann Emerg Med; 1997 Feb; 29(2):287-9. PubMed ID: 9018197
[TBL] [Abstract][Full Text] [Related]
18. [Likely serotoninergic syndrome from an interaction between amitryptiline, paroxetine, and linezolid].
Morales-Molina JA; Mateu-de Antonio J; Grau Cerrato S; Marín Casino M
Farm Hosp; 2005; 29(4):292-3. PubMed ID: 16268747
[No Abstract] [Full Text] [Related]
19. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
Nordeng H; Lindemann R; Perminov KV; Reikvam A
Acta Paediatr; 2001 Mar; 90(3):288-91. PubMed ID: 11332169
[TBL] [Abstract][Full Text] [Related]
20. [Paroxetine withdrawal syndrome as differential diagnosis of acute neonatal encephalopathy?].
Herbst F; Gortner L
Z Geburtshilfe Neonatol; 2003; 207(6):232-4. PubMed ID: 14689334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
